Setor de Dor
São Paulo, 04023-062, Brazil
NCT Number: NCT01381380
This study is a pain intensity evaluation in patients with myofascial pain submitted kinesitherapy after trigger point injection.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
São Paulo, 04023-062, Brazil
Randomized prospective study conducted on 30 patients of both genders ranging in age from 18 to 60 years, with neck and shoulder girdle Myofascial Pain Syndrome (MFS), with a duration of ≥ 4 months and pain intensity ≥ 4.
Trigger point injection of 1 mL 0.25% bupivacaine at each point, once a week for 8 weeks (T1 to T8).
Group 1: kinesiotherapy once a week for 8 weeks Group 2: not submitted to kinesiotherapy Evaluation of pain intensity on the first assessment (T0) and after 1, 2, 3, 4, 5, 6, 7, 8, and 9 weeks
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Manual therapy, once a week for 8 weeks
Other names: massage, finger pressure, myofascial release, mobilization
Time frame: 8 weeks
once a week for 8 weeks (T1 to T8)
Federal University of São Paulo
Other
Effect of Manual Therapy After Trigger Point Injection for Myofascial Pain Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07515352
Muscular Diseases, Musculoskeletal Diseases
Kannur, Kerala, India
View Trial DetailsNCT07410221
Agnosia, Anxiety Disorders
Istanbul, Merkez, Turkey (Türkiye)
View Trial DetailsNCT02436096
Connective Tissue Diseases, Fibromyalgia
Birmingham, Alabama, United States
View Trial DetailsNCT06768281
Muscular Diseases, Musculoskeletal Diseases
Istanbul, Fatih, Turkey (Türkiye)
View Trial Details